Cipla

Takeda gives Sun Pharma, Cipla rights to commercialize gastro drug in India
Reuters
Fri, 06/21/24 - 11:02 am
Takeda
Sun Pharma
Cipla
India
GERD
vonoprazan
Gilead can't escape antitrust suit centered on pay-for-delay deal with Cipla, judge says
Fierce Pharma
Tue, 08/23/22 - 10:24 pm
Gilead Sciences
Cipla
pay-for-delay
legal generics
Emtriva
Viread
India's hesitance to condemn Russia puts the country's pharma industry in compromising position
Fierce Pharma
Wed, 03/9/22 - 12:00 pm
Russia
Ukraine
India
Cipla
Dr Reddy's
Torrent Pharmaceuticals
Sun Pharma
The difficult momentum of Indian pharma sector
GoinPharma
Sun, 03/25/18 - 11:22 am
India
generics
Sun Pharma
Cipla
Dr Reddy's
Lupin
FDA Approves First Generic Versions of Amgen’s Sensipar
RAPS.org
Thu, 03/8/18 - 07:27 pm
FDA
generics
Amgen
Sensipar
Cipla
Aurobindo
Glenmark, Sun Pharma, Cipla Said to Weigh Bid for Teva Portfolio
Bloomberg
Thu, 11/19/15 - 09:44 am
Glenmark
Sun Pharma
Cipla
M&A
Teva Pharmaceutical
generics
Cipla runs into FDA concerns for plant in India, as well as one it will buy in U.S.
Fierce Pharma
Tue, 10/20/15 - 09:51 pm
India
Cipla
FDA
drug manufacturing
Cipla Steps Up U.S. Expansion With $550 Million Acquisitions
Bloomberg
Fri, 09/4/15 - 09:03 am
Cipla
India
generics
Interview - Cipla expects to double sales of respiratory drugs by 2020
Yahoo/Reuters
Wed, 06/17/15 - 10:12 am
Cipla
India
respiratory health
asthma
generics
UCB reportedly gets bids for Kremers Urban unit from Cipla and Lupin
Fierce Pharma
Mon, 06/1/15 - 07:12 pm
UCB Pharma
Cipla
M&A
Kremers Urban Pharmaceuticals
Lupin
Indian pharma giants scuffle to snap up injectables maker Claris
BioPharma Dive
Fri, 02/13/15 - 10:30 am
India
injectables
M&A
Claris Lifesciences
Lupin
Cipla
Zydus Cadilla
Pfizer
Aspen, Cipla win share of $860 mln S.Africa AIDS drug tender
Yahoo/Reuters
Wed, 12/24/14 - 09:14 am
Aspen Pharmacare
Cipla
AIDS
South Africa
Novartis sues Cipla over respiratory drug Onbrez
Yahoo/Reuters
Wed, 12/17/14 - 09:57 am
Novartis
Cipla
Onbrez
Generic Sovaldi makers could pocket upwards of $600m says analyst
In-Pharma Technologist
Thu, 09/25/14 - 09:25 am
generics
Sovaldi
Gilead Sciences
hepatitis C
Mylan
Strides Arcolab
Cadila
Cipla
Hetero Labs
Ranbaxy
Sequent Scientific
Gilead signs pact with 7 firms for cheap copies of hepatitis C drug
Yahoo/Reuters
Mon, 09/15/14 - 08:49 am
Gilead Sciences
Sovaldi
generics
hepatitis C
Cipla
Ranbaxy
Cadila
Mylan Labs
Strides Arcolab
Hetero Drugs
Sequent Scientific
Cipla Targets U.S. With Glaxo’s Advair, Anti-AIDS Drugs
Bloomberg
Mon, 09/1/14 - 10:41 am
Cipla
GSK
AIDS
Advair
generics
Cipla’s Drug Pipeline Makes It $10 Billion Prey: Real M&A
Bloomberg
Wed, 06/18/14 - 04:23 am
Cipla
M&A
India
Mylan
Teva Pharmaceuticals
Cipla Rises as Teva Reported to Woo Indian Drugmaker
Bloomberg
Fri, 05/9/14 - 10:36 am
Teva Pharmaceuticals
Cipla
M&A
India
Merck HIV Drug Strategy Seen Shielding Patent: Corporate India
Bloomberg
Thu, 03/20/14 - 08:30 am
HIV
Merck
India
Cipla
Isentress
patents
Enbrel's Asian Biosimilar Competitors
Seeking Alpha
Fri, 04/26/13 - 10:50 am
biosimilars
Enbrel
Amgen
Cipla
Pfizer
Etacept
rheumatoid arthritis

Pages